Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Y2K liability legislation

This article was originally published in The Gray Sheet

Executive Summary

HR 775 is cleared for the President's signature following adoption of the conference report by the Senate (81-18) and House (404-24) on July 1. A compromise was reached with the White House on June 29, clearing the way for final passage and avoiding a threatened veto. The bill caps punitive damages to firms of less than 50 employees at $250,000 or three times compensatory damages, whichever is less, except in cases with fraud. The deal also included alternate language on the obligation of manufacturers to minimize Y2K-related problems

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012020

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel